Research Daily Summary
Research Daily Summary: What Happened on November 17, 2026
Blood test separates advanced Alzheimer’s tau pathology
A five-study analysis linked memory gains across generations with lower dementia incidence. Parkinson’s researchers completed a 5,500-sample protein analysis.
Today in brief
An immunoassay detected advanced tau pathology in Alzheimer’s disease with performance similar to mass spectrometry, using a much smaller plasma sample.1 Across five long-term studies, people born later had better memory in old age and declined more slowly.2
Also worth knowing
-
Researchers investigating a death during a gene-therapy trial did not establish its precise cause and proposed experiments to screen for the newly recognized risk in future therapies.3
-
B
The Michael J. Fox Foundation and Thermo Fisher Scientific completed a proteomic analysis of 5,500 Parkinson’s Precision Medicine Initiative samples. Researchers reported early associations between immune markers and genetic Parkinson’s cohorts.4